Clinical trial condition

HNSCC

Explore clinical trials studying HNSCC. Study availability and eligibility vary by location and protocol.

78 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

HNSCC trial results

Not yet recruiting

Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial

NCT07491783

Conditions: Carcinoma, Carcinoma, Squamous Cell, HNSCC, +9 more
Locations: West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Not yet recruiting

Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis

NCT07246759

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +41 more
Locations: Heidelberg University Hospital Heidelberg, Germany

Intituto Europeo di Oncologia SRL Milan, Italy

Virgen Macarena University Hospital - Servicio Andaluz de Salud Seville, Spain

View Trial Details

Not yet recruiting

PD-1 Inhibitor Therapy Versus Radiotherapy in MPR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy (HNC-SYSU-006)

NCT07090707

Conditions: Carcinoma, Carcinoma, Squamous Cell, HNSCC, +8 more
Locations: Sun yat-sen memorial hospital Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

NCT06719479

Conditions: Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

Tirelizumab in Combination With Carboplatin and Polymeric Micellar Paclitaxel for Neoadjuvant Therapy in cN+ HNSCC

NCT06366945

Conditions: Carcinoma, Carcinoma, Squamous Cell, HNSCC, +9 more
Locations: Not specified

View Trial Details

Active, not recruiting

Induction Chemoimmunotherapy Followed by Deescalated Definitive Radiotherapy in Head and Neck Cancer

NCT07791602

Conditions: Carcinoma, Carcinoma, Squamous Cell, HNSCC, +8 more
Locations: Air Force Medical Center Beijing, China

Peking Union Medical College Hospital Beijing, China

Harbin Medical University Cancer Hospital Harbin, China

Cancer Hospital of Dalian University of Technology （Liaoning Cancer Hospital & Institute） Shenyang, China

View Trial Details

Active, not recruiting

Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma

NCT06673693

Conditions: Carcinoma, Carcinoma, Squamous Cell, HNSCC, +7 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, not recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT05581004

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +57 more
Locations: Stanford University San Francisco, California, United States

University Of Colorado Aurora, Colorado, United States

Florida Cancer Specialists - Sarasota Sarasota, Florida, United States

Winship Cancer Institute Atlanta, Georgia, United States

View all 36 locations

View Trial Details

Active, not recruiting

A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma

NCT07010120

Conditions: Carcinoma, Carcinoma, Squamous Cell, HNSCC, +10 more
Locations: Department of Radiation Oncology Chengdu, Sichuan, China

View Trial Details

Active, not recruiting

Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC

NCT04340258

Conditions: Carcinoma, Carcinoma, Squamous Cell, HNSCC, +6 more
Locations: University of Cincinnati Medical Center Cincinnati, Ohio, United States

Thomas Jefferson Philadelphia, Pennsylvania, United States

View Trial Details

HNSCC

HNSCC trial results

Related conditions